Journal of Autoimmunity

Article	Citations
The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak	3272
The deadly coronaviruses: The 2003 SARS pandemic and the 2020 novel coronavirus epidemic in China	609
Can we use interleukin-6 (IL-6) blockade for coronavirus disease 2019 (COVID-19)-induced cytokine release syndrome (CRS)?	536
The etiology of rheumatoid arthritis	347
The 2022 outbreak and the pathobiology of the monkeypox virus	260
Autoinflammatory and autoimmune conditions at the crossroad of COVID-19	226
Assessing ACE2 expression patterns in lung tissues in the pathogenesis of COVID-19	212
Evolutionary analysis of the Delta and Delta Plus variants of the SARS-CoV-2 viruses	200
Omicron SARS-CoV-2 variant: Unique features and their impact on pre-existing antibodies	165
Characteristics and prognostic factors of disease severity in patients with COVID-19: The Beijing experience	159
An overview of autoantibodies in rheumatoid arthritis	158
Complement activation and endothelial perturbation parallel COVID-19 severity and activity	118
Mechanisms of Immunothrombosis in Vaccine-Induced Thrombotic Thrombocytopenia (VITT) Compared to Natural SARS-CoV-2 Infection	117
The pathogenesis, diagnosis and clinical manifestations of steroid-induced osteonecrosis	112
Systemic autoinflammatory diseases	104
Inflammatory markers in systemic lupus erythematosus	99
Treg cells in health and autoimmune diseases: New insights from single cell analysis	98
Recommendations for coronavirus infection in rheumatic diseases treated with biologic therapy	94
Mitigating Covid-19 in the face of emerging virus variants, breakthrough infections and vaccine hesitancy	94
COVID-19 convalescent plasma composition and immunological effects in severe patients	90
The anti-viral facet of anti-rheumatic drugs: Lessons from COVID-19	90
The pathogenesis of systemic lupus erythematosus: Harnessing big data to understand the molecular basis of lupus	85
Ferritin – from iron, through inflammation and autoimmunity, to COVID-19	84
Autoimmune hepatitis triggered by SARS-CoV-2 vaccination	84
SARS-CoV-2 infection in patients with autoimmune rheumatic diseases in northeast Italy: A cross-sectional study on 916 patients	83

Impaired immunogenicity to COVID-19 vaccines in autoimmune systemic diseases. High prevalence of non-response in different patients’ subgroups	83
The immunobiology of mTOR in autoimmunity	77
Acute autoimmune-like hepatitis with atypical anti-mitochondrial antibody after mRNA COVID-19 vaccination: A novel clinical entity?	73
Auto-immune hepatitis following COVID vaccination	71
Sjögren's syndrome: Old and new therapeutic targets	71
Interleukin-6 receptor blocking with intravenous tocilizumab in COVID-19 severe acute respiratory distress syndrome: A retrospective case-control survival analysis of 128 patients	68
Autoimmune hepatitis after COVID-19 vaccine – more than a coincidence	66
The JANUS of chronic inflammatory and autoimmune diseases onset during COVID-19 – A systematic review of the literature	66
A case of Graves' disease and type 1 diabetes mellitus following SARS-CoV-2 vaccination	62
Clinical significance of miRNAs in autoimmunity	60
Precision medicine and management of rheumatoid arthritis	53
Clinical characteristics and predictors of survival in adults with coronavirus disease 2019 receiving tocilizumab	53
Autoimmune hepatitis after SARS-CoV-2 vaccine: New-onset or flare-up?	52
Autoantibodies against ACE2 and angiotensin type-1 receptors increase severity of COVID-19	52
Blood clots and bleeding events following BNT162b2 and ChAdOx1 nCoV-19 vaccine: An analysis of European data	51
Safety and efficacy of fecal microbiota transplantation for treatment of systemic lupus erythematosus: An EXPLORER trial	50
The roles of PPARγ and its agonists in autoimmune diseases: A comprehensive review	50
Marginal zone B cells: From housekeeping function to autoimmunity?	49
The progress and prospect of regulatory T cells in autoimmune diseases	48
Recent advances in the NEK7-licensed NLRP3 inflammasome activation: Mechanisms, role in diseases and related inhibitors	46
Innate immunity as the trigger of systemic autoimmune diseases	46
JAK/STAT signaling controls the fate of CD8+CD103+ tissue-resident memory T cell in lupus nephritis	46
Resistant starch intake alleviates collagen-induced arthritis in mice by modulating gut microbiota and promoting concomitant propionate production	44
Experience with tocilizumab in severe COVID-19 pneumonia after 80 days of follow-up: A retrospective cohort study	44
Perspectives on vaccine induced thrombotic thrombocytopenia	43
Autoimmune and autoinflammatory conditions after COVID-19 vaccination. New case reports and updated literature review	43
Chromosome 3 cluster rs11385942 variant links complement activation with severe COVID-19	43
A prospective multicenter study assessing humoral immunogenicity and safety of the mRNA SARS-CoV-2 vaccines in Greek patients with systemic autoimmune and autoinflammatory rheumatic diseases	43
High dose subcutaneous Anakinra to treat acute respiratory distress syndrome secondary to cytokine storm syndrome among severely ill COVID-19 patients	42
Cardiovascular, neurological, and pulmonary events following vaccination with the BNT162b2, ChAdOx1 nCoV-19, and Ad26.COV2.S vaccines: An analysis of European data	42
Coronavirus disease 2019, immune-mediated inflammatory diseases and immunosuppressive therapies – A Danish population-based cohort study	40
Autoantibodies to neutrophil extracellular traps represent a potential serological biomarker in rheumatoid arthritis	40
Gut microbiota differently contributes to intestinal immune phenotype and systemic autoimmune progression in female and male lupus-prone mice	39
Mushrooms and immunity	38
EZH2 deficiency attenuates Treg differentiation in rheumatoid arthritis	38
Abnormalities of T cells in systemic lupus erythematosus: new insights in pathogenesis and therapeutic strategies	37
Cardiovascular disease risk in antiphospholipid syndrome: Thrombo-inflammation and atherothrombosis	37
Extracellular vesicles and lupus nephritis - New insights into pathophysiology and clinical implications	36
Evolving story of autoantibodies in systemic lupus erythematosus	36
Durable antibody response one year after hospitalization for COVID-19: A longitudinal cohort study	36
Leukocytoclastic vasculitis (cutaneous small-vessel vasculitis) after COVID-19 vaccination	35
New developments implicating IL-21 in autoimmune disease	35
Clinical disease activity and flare in SLE: Current concepts and novel biomarkers	35
Regulatory T cells in autoimmune hepatitis: an updated overview	34
Innate inflammation drives NK cell activation to impair Treg activity	34
Best practices for detection, assessment and management of suspected immune-mediated liver injury caused by immune checkpoint inhibitors during drug development	33
Comparison of vaccine-induced thrombotic events between ChAdOx1 nCoV-19 and Ad26.COV.2.S vaccines	33
The pivotal role of CD69 in autoimmunity	32
Disordered cutaneous microbiota in systemic lupus erythematosus	32
Treg-specific IL-2 therapy can reestablish intrahepatic immune regulation in autoimmune hepatitis	31

Short-chain fatty acid butyrate induces IL-10-producing B cells by regulating circadian-clock-related genes to ameliorate Sjögren's syndrome	31
Lupus nephritis: new progress in diagnosis and treatment	31
Unique autoantibody prevalence in long-term recovered SARS-CoV-2-infected individuals	30
An autoantigen profile of human A549 lung cells reveals viral and host etiologic molecular attributes of autoimmunity in COVID-19	29
Cell-autonomous epithelial activation of AIM2 (absent in melanoma-2) inflammasome by cytoplasmic DNA accumulations in primary Sjögren's syndrome	29
Gene expression profiling of epithelium-associated FcRL4+ B cells in primary Sjögren's syndrome reveals a pathogenic signature	29
Relapsed and newly diagnosed Graves’ disease due to immunization against COVID-19: A case series and review of the literature	29
Histone deacetylase 1 (HDAC1): A key player of T cell-mediated arthritis	29
Intestinal permeability in type 1 diabetes: An updated comprehensive overview	29
A comprehensive analysis of the clinical characteristics and laboratory features in 179 patients with autoimmune autonomic ganglionopathy	29
Mesenchymal stromal cells-derived extracellular vesicles alleviate systemic sclerosis via miR-29a-3p	28
Bi-directional communication: Conversations between fibroblasts and immune cells in systemic sclerosis	28
Comprehensive TCR repertoire analysis of CD4+ T-cell subsets in rheumatoid arthritis	27
Antagonizing miR-7 suppresses B cell hyperresponsiveness and inhibits lupus development	27
Severe aplastic anemia after COVID-19 mRNA vaccination: Causality or coincidence?	27
Cardiac involvement in adult-onset Still's disease: Manifestations, treatments and outcomes in a retrospective study of 28 patients	27
Corrigendum to “The deadly coronaviruses: The 2003 SARS pandemic and the 2020 novel coronavirus epidemic in China” [J. Autoimmun. 109C (2020) 102434]	27
Pirfenidone alleviates lipopolysaccharide-induced lung injury by accentuating BAP31 regulation of ER stress and mitochondrial injury	27
CXCL4 triggers monocytes and macrophages to produce PDGF-BB, culminating in fibroblast activation: Implications for systemic sclerosis	26
Profiling of the immune repertoire in COVID-19 patients with mild, severe, convalescent, or retesting-positive status	26
Experimental evidence of pathogenic role of IgG autoantibodies in IgA nephropathy	26
Insights into the treatment of rheumatoid arthritis: A paradigm in medicine	26
Selective targeting of PI3Kδ suppresses human IL-17-producing T cells and innate-like lymphocytes and may be therapeutic for IL-17-mediated diseases	25
Guideline for the diagnosis, treatment and long-term management of cutaneous lupus erythematosus	25
Microscopic polyangiitis: Clinical characteristics and long-term outcomes of 378 patients from the French Vasculitis Study Group Registry	25
Human gingiva-derived mesenchymal stem cells are therapeutic in lupus nephritis through targeting of CD39−CD73 signaling pathway	25
Alveolar haemorrhage in ANCA-associated vasculitis: Long-term outcome and mortality predictors	25
Multi-omics: Differential expression of IFN-γ results in distinctive mechanistic features linking chronic inflammation, gut dysbiosis, and autoimmune diseases	25
The complement system and human autoimmune diseases	25
Autoimmune dysautonomia in women with silicone breast implants	24
Prevention and cure: The major unmet needs in the management of rheumatoid arthritis	24
LAG3 (CD223) and autoimmunity: Emerging evidence	24
Mutations in the monkeypox virus replication complex: Potential contributing factors to the 2022 outbreak	24
Insights into interplay of immunopathophysiological events and molecular mechanistic cascades in psoriasis and its associated comorbidities	23
Durable renal response and safety with add-on belimumab in patients with lupus nephritis in real-life setting (BeRLiSS-LN). Results from a large, nationwide, multicentric cohort	23
Treat to target in axial spondyloarthritis: From its concept to its implementation	23
A biomarker for lymphoma development in Sjogren's syndrome: Salivary gland focus score	23
Integrated bulk and single-cell RNA-sequencing identified disease-relevant monocytes and a gene network module underlying systemic sclerosis	22
Dendritic cells in systemic lupus erythematosus: From pathogenesis to therapeutic applications	22
A multidisciplinary registry of patients with autoimmune and immune-mediated diseases with symptomatic COVID-19 from a single center	22
Correction of autophagy impairment inhibits pathology in the NOD.H-2h4 mouse model of primary Sjögren's syndrome	22
Gut microbiota in systemic lupus erythematosus: A fuse and a solution	22
T helper cell immunity in pregnancy and influence on autoimmune disease progression	22
Resident human dermal γδT-cells operate as stress-sentinels: Lessons from the hair follicle	21
Short term outcomes of COVID-19 in lupus: Propensity score matched analysis from a nationwide multi-centric research network	21
Longitudinal analysis of T-cell receptor repertoires reveals persistence of antigen-driven CD4+ and CD8+ T-cell clusters in systemic sclerosis	21
Pathogenesis, multi-omics research, and clinical treatment of psoriasis	21
Endoplasmic reticulum-associated degradation and beyond: The multitasking roles for HRD1 in immune regulation and autoimmunity	20
Autoantibodies in systemic lupus erythematosus: From immunopathology to therapeutic target	20
Association of the CXCL9-CXCR3 and CXCL13-CXCR5 axes with B-cell trafficking in giant cell arteritis and polymyalgia rheumatica	20
Early diagnosis and treatment for Sjögren's syndrome: current challenges, redefined disease stages and future prospects	20
Monoclonal antibodies from B cells of patients with anti-MDA5 antibody-positive dermatomyositis directly stimulate interferon gamma production	20
Prevalence of COVID infections in a population of rheumatic patients from Lombardy and Marche treated with biological drugs or small molecules: A multicentre retrospective study	20
CD137 / CD137 ligand signalling regulates the immune balance: A potential target for novel immunotherapy of autoimmune diseases	20
Transcriptome landscape of double negative T cells by single-cell RNA sequencing	20
Insights into the knowledge of complex diseases: Environmental infectious/toxic agents as potential etiopathogenetic factors of systemic sclerosis	20
Telomeres: New players in immune-mediated inflammatory diseases?	19
Rituximab plus belimumab in non-infectious refractory cryoglobulinemia vasculitis: A pilot study	19
Mitochondrial N-formyl methionine peptides associate with disease activity as well as contribute to neutrophil activation in patients with rheumatoid arthritis	19
TLR expression profiles are a function of disease status in rheumatoid arthritis and experimental arthritis	18
Antiphospholipid antibodies can specifically target placental mitochondria and induce ROS production	18
High T-cell response rate after COVID-19 vaccination in belimumab and rituximab recipients	18
COVID-19 infection among autoimmune rheumatic disease patients: Data from an observational study and literature review	18
Alteration of CD226/TIGIT immune checkpoint on T cells in the pathogenesis of primary Sjögren's syndrome	18
Galectin-9 bridges human B cells to vascular endothelium while programming regulatory pathways	18
Autoimmune conditions following mRNA (BNT162b2) and inactivated (CoronaVac) COVID-19 vaccination: A descriptive cohort study among 1.1 million vaccinated people in Hong Kong	17
Outcome of COVID-19 in hospitalized patients with chronic inflammatory diseases. A population based national register study in Denmark	17
Prognosis of large vessel involvement in large vessel vasculitis	17
Homocysteinylated alpha 1 antitrypsin as an antigenic target of autoantibodies in seronegative rheumatoid arthritis patients	17
Treatment of experimental autoimmune encephalomyelitis with engineered bi-specific Foxp3+ regulatory CD4+ T cells	16
A recommended paradigm for vaccination of rheumatic disease patients with the SARS-CoV-2 vaccine	16
Comparison of conventional immunosuppressive drugs versus anti-TNF-α agents in non-infectious non-anterior uveitis	16
Cellular and molecular regulation of the programmed death-1/programmed death ligand system and its role in multiple sclerosis and other autoimmune diseases	16
Primary biliary cholangitis with normal alkaline phosphatase: A neglected clinical entity challenging current guidelines	15
Antiphospholipid autoantibody detection is important in all patients with systemic autoimmune diseases	15
HLA class I hyper-expression unmasks beta cells but not alpha cells to the immune system in pre-diabetes	14
Neutrophil-derived extracellular vesicles induce endothelial inflammation and damage through the transfer of miRNAs	14
Immune recognition of lysyl-tRNA synthetase and isoleucyl-tRNA synthetase by anti-OJ antibody-positive sera	14
A novel mutation of indoleamine 2,3-dioxygenase 1 causes a rapid proteasomal degradation and compromises protein function	14
TIGIT+ A2Ar-Dependent anti-uveitic Treg cells are a novel subset of Tregs associated with resolution of autoimmune uveitis	14

Anti-Ro60 and anti-Ro52/TRIM21: Two distinct autoantibodies in systemic autoimmune diseases	13
Modulating the wayward T cell: New horizons with immune checkpoint inhibitor treatments in autoimmunity, transplant, and cancer	13
Adenosine-to-inosine RNA editing contributes to type I interferon responses in systemic sclerosis	13
Interferon signature in giant cell arteritis aortitis	13
Autoimmune hepatitis following COVID-19 vaccination	13
Recombinant thrombomodulin ameliorates autoimmune vasculitis via immune response regulation and tissue injury protection	13
Dual-Targeted Autoimmune Sword in Fatal Epilepsy: Patient's glutamate receptor AMPA GluR3B peptide autoimmune antibodies bind, induce Reactive Oxygen Species (ROS) in, and kill both human neural cells	13
Are lupus animal models useful for understanding and developing new therapies for human SLE?	13
Tracking immunodynamics by identification of S-G2/M-phase T cells in human peripheral blood	13
Subjects at-risk for future development of rheumatoid arthritis demonstrate a PAD4-and TLR-dependent enhanced histone H3 citrullination and proinflammatory cytokine production in CD14hi monocytes	12
Kinase activity profiling reveals contribution of G-protein signaling modulator 2 deficiency to impaired regulatory T cell migration in rheumatoid arthritis	12
Alterations in corneal biomechanics underlie early stages of autoimmune-mediated dry eye disease	12
Autoreactive T cells and their role in atopic dermatitis	12
Thrombocytopenia after COVID-19 vaccination	12
Enhanced type I interferon signature induces neutrophil extracellular traps enriched in mitochondrial DNA in adult-onset Still's disease	12
Systemic lupus erythematosus-complicating immune thrombocytopenia: From pathogenesis to treatment	12
Prospects for the potential of RNA interference in the treatment of autoimmune diseases: Small interfering RNAs in the spotlight	12
Pregnancy and neonatal outcomes in women with immune mediated inflammatory diseases exposed to anti-tumor necrosis factor-α during pregnancy: A systemic review and meta-analysis	12
Gut microbiota in pre-clinical rheumatoid arthritis: From pathogenesis to preventing progression	11
T follicular helper cells in autoimmune diseases	11
Utility of circulating serum miRNA profiles to evaluate the potential risk and severity of immune-mediated inflammatory disorders	11
B cell-targeted therapies in systemic lupus erythematosus	11
SARS-CoV-2 vaccination and risk of severe COVID-19 outcomes in patients with autoimmune hepatitis	11
Molecular mimicry and autoimmunity in the time of COVID-19	11
Autophagy pathways in autoimmune diseases	11
Targeting the endo-lysosomal autophagy pathway to treat inflammatory bowel diseases	11
Diffuse cutaneous systemic sclerosis following SARS-Co V-2 vaccination	11
RNA-binding protein hnRNP UL1 binds κB sites to attenuate NF-κB-mediated inflammation	11
Infectious diseases, autoantibodies, and autoimmunity	11
Fecal microbiota transplantation: Emerging applications in autoimmune diseases	11
Genetic and transcriptomic analyses support a switch to lytic phase in Epstein Barr virus infection as an important driver in developing Systemic Lupus Erythematosus	10
Evolving spectrum of drug-induced uveitis at the era of immune checkpoint inhibitors results from the WHO's pharmacovigilance database	10
Tissue alarmins and adaptive cytokine induce dynamic and distinct transcriptional responses in tissue-resident intraepithelial cytotoxic T lymphocytes	10
Absent or suboptimal response to booster dose of COVID-19 vaccine in patients with autoimmune systemic diseases	10
New insights into the taxonomy of autoimmune diseases based on polyautoimmunity	10
Pathological mechanisms and crosstalk among different forms of cell death in systemic lupus erythematosus	10
Novel autoantibodies to the β-cell surface epitopes of ZnT8 in patients progressing to type-1 diabetes	10
Systemic lupus erythematosus, endothelial progenitor cells and intracellular Ca2+ signaling: A novel approach for an old disease	10
A Guillain-Barré syndrome-associated SIGLEC10 rare variant impairs its recognition of gangliosides	10
A cyclic peptide significantly improves thyroid function, thyrotropin-receptor antibodies and orbital mucine /collagen content in a long-term Graves’ disease mouse model	10
Involvement of trained immunity during autoimmune responses	10
Mechanistic insight into premature atherosclerosis and cardiovascular complications in systemic lupus erythematosus	10
Retro-inverso D-peptides as a novel targeted immunotherapy for Type 1 diabetes	10
ETS-1 facilitates Th1 cell-mediated mucosal inflammation in inflammatory bowel diseases through upregulating CIRBP	10
Cepharanthine blocks TSH receptor peptide presentation by HLA-DR3: Therapeutic implications to Graves’ disease	10
Altered lipid metabolism in synovial fibroblasts of individuals at risk of developing rheumatoid arthritis	10
Evaluation of humoral and cellular response to third dose of BNT162b2 mRNA COVID-19 vaccine in patients treated with B-cell depleting therapy	10
Immune-mediated enteropathies: From bench to bedside	9
Flagellin-specific human CAR Tregs for immune regulation in IBD	9
Gluten-free diet reduces autoimmune diabetes mellitus in mice across multiple generations in a microbiota-independent manner	9
Sex-specific analysis in Behçet's disease reveals higher genetic risk in male patients	9
Nuclear translocation of RIG-I promotes cellular apoptosis	9
Skin CD4+ Trm cells distinguish acute cutaneous lupus erythematosus from localized discoid lupus erythematosus/subacute cutaneous lupus erythematosus and other skin diseases	9
Risk of ankylosing spondylitis following human papillomavirus infection: A nationwide, population-based, cohort study	9
Interferon (IFN)-stimulated gene 15: A novel biomarker for lymphoma development in Sjögren's syndrome	9
Advances in SLE classification criteria	9
A novel humanized cutaneous lupus erythematosus mouse model mediated by IL-21-induced age-associated B cells	9
Research progress of single-cell transcriptome sequencing in autoimmune diseases and autoinflammatory disease: A review	9
Genomic instability in early systemic sclerosis	9
Poor responses and adverse outcomes of myasthenia gravis after thymectomy: Predicting factors and immunological implications	9
Post-mRNA vaccine flares in autoimmune inflammatory rheumatic diseases: Results from the COronavirus National Vaccine registry for ImmuNe diseases SINGapore (CONVIN-SING)	9
Anti-neutrophil cytoplasmic antibodies predate symptom onset of ANCA-associated vasculitis. A case-control study	9
Role of mitochondria in the myopathy of juvenile dermatomyositis and implications for skeletal muscle calcinosis	8
Tissue-specific activation of Myd88-dependent pathways governs disease severity in primary Sjögren's syndrome	8
Identification of Ribosomal Protein S4, Y-Linked 1 as a cyclosporin A plus corticosteroid resistance gene	8
Liver X receptor beta deficiency attenuates autoimmune-associated neuroinflammation in a T cell-dependent manner	8
Identification of a primary antigenic target of epitope spreading in endemic pemphigus foliaceus	8
Antigen-specific immune reactions by expanded CD8+ T cell clones from HLA-B*27-positive patients with spondyloarthritis	8
Genetic association and differential expression of HLA Complex Group lncRNAs in pemphigus	8
Genetic and pharmacological targeting of GSDMD ameliorates systemic inflammation in macrophage activation syndrome	8
Autoimmunity to neuroretina in the concurrent absence of IFN-γ and IL-17A is mediated by a GM-CSF-driven eosinophilic inflammation	8
Gut microbiome, metabolome, host immunity associated with inflammatory bowel disease and intervention of fecal microbiota transplantation	8
Distinct patterns of comorbidity prior to diagnosis of incident systemic lupus erythematosus in the Danish population	8
Pre-existing conditions associated with post-acute sequelae of COVID-19	8
MTADV 5-MER peptide suppresses chronic inflammations as well as autoimmune pathologies and unveils a new potential target-Serum Amyloid A	8
Chronic inflammation and extracellular matrix-specific autoimmunity following inadvertent periarticular influenza vaccination	7
Long-term renal prognosis among patients with primary Sjögren's syndrome and renal involvement: A nationwide matched cohort study	7
IgG anti-Pentraxin 3 antibodies are a novel biomarker of ANCA-associated vasculitis and better identify patients with eosinophilic granulomatosis with polyangiitis	7
Disease activity in patients with immune-mediated inflammatory diseases after SARS-CoV-2 vaccinations	7
Do RA associated HLA-DR molecules bind citrullinated peptides or peptides from PAD4 to help the development of RA specific antibodies to citrullinated proteins?	7
Identification of new telomere- and telomerase-associated autoantigens in systemic sclerosis	7
The amino acid variants in HLA II molecules explain the major association with adult-onset Still's disease in the Han Chinese population	7
Distinct gene dysregulation patterns herald precision medicine potentiality in systemic lupus erythematosus	7
IL-17 is expressed on beta and alpha cells of donors with type 1 and type 2 diabetes	7
Immunization with Pentraxin3 prevents transition from subclinical to clinical lupus nephritis in lupus-prone mice: Insights from renal ultrastructural findings	7
Transcriptomic profiling of iris tissue highlights LCK signaling and T cell-mediated immunity in Behcet's uveitis	7
Identifying the most influential gene expression profile in distinguishing ANCA-associated vasculitis from healthy controls	7
Erythropoietin administration expands regulatory T cells in patients with autoimmune hepatitis	7
Histone deacetylase 1 controls CD4+ T cell trafficking in autoinflammatory diseases	7
Cutaneous involvement in anti-HMGCR positive necrotizing myopathy	7
Glucocorticoid use as a cause of non-cellular immune response to SARS-Cov2 Spike in patients with immune system diseases	7
Non-coding RNAs in immunoregulation and autoimmunity: Technological advances and critical limitations	7
Supraphysiological FOXP3 expression in human CAR-Tregs results in improved stability, efficacy, and safety of CAR-Treg products for clinical application	7
COVID-19 outcomes in giant cell arteritis and polymyalgia rheumatica versus rheumatoid arthritis: A national, multicenter, cohort study	7
Disease status in human and experimental arthritis, and response to TNF blockade, is associated with MHC class II invariant chain (CD74) isoform expression	7